Skip to main content

An open-label, long-term safety and tolerability study of b1ivaracetam as adjunctive treatment in pediatric study participants with epilepsy

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neurology

Awarded By

UCB Biopharma

Start Date

May 12, 2021

End Date

January 31, 2023
 

Administered By

Pediatrics, Neurology

Awarded By

UCB Biopharma

Start Date

May 12, 2021

End Date

January 31, 2023